Karyopharm announces poster presentation on selinexor in myelofibrosis at the 2025 european hematology association annual meeting

Newton, mass. , may 14, 2025 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract has been selected for a poster presentation at the 2025 european hematology association annual meeting (eha) being held june 12-15 in milan, italy.
KPTI Ratings Summary
KPTI Quant Ranking